Work

Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): A therapeutic advances in childhood leukemia (TACL) consortium study

Year: 2010

Type: article

Study design: Observational Study

Source: Pediatric Blood & Cancer

DOI: 10.1002/pbc.22612

Authors: Matthew F. Gorman, Lingyun Ji, Richard H. Ko, Phillip Barnette, Bruce Bostrom, Raymond Hutchinson, Elizabeth Raetz, Nita L. Seibel, Clare J. Twist, Elena Eckroth, Richard Sposto, Paul S. Gaynon, Mignon L. Loh

Institutions: University of Southern California, Children's Hospital Los Angeles, University of California, San Francisco, Primary Children's Hospital, Children's Minnesota, C. S. Mott Children's Hospital, NYU Langone Health, Children's National, George Washington University, Stanford Medicine

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Leukemia and Lymphoma Society, Frank A. Campini Foundation, National Institutes of Health, National Cancer Institute

Awards: Ras Pathway Mutations in Human Leukemia, G5151231627

OpenAlex ID: W2155514224

FWCI: 2.995

Cites: 39

Cited by: 110

Related to: 10